Arnatar Therapeutics
PrivateLast Round
Series A
Apr 9, 2024
Total Funding Raised
$115.8M
Momentum Score
50 /100
Company Overview
Arnatar Therapeutics is a biotechnology company focused on developing antisense nucleic acid technology-based drugs for the treatment of metabolic diseases and serious rare conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arnatar Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Arnatar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 9, 2024 | ||||
| Seed | Sep 19, 2022 |
Key People
Founding team and executive leadership
Arnatar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series A |
| New Alliance Capital | Series A |
| Legend Star | Series A |
| Bencao Capital | Series A |
| Eight Roads Ventures | Series A |
| Transfar Group | Series A |
| Huajin Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 142% MoM, reaching 2.1K.
- Feb 5, 2026
Therapeutic candidate advanced into human trials.
Arnatar Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arnatar Therapeutics's valuation, stock price, and market status.
